Marshall Wace, LLP Ibere Pharmaceuticals Transaction History

Marshall Wace, LLP

  • $72.2 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.11 - $9.94 $838 - $75,762
7,622 Added 1.43%
539,807 $5.35 Million
Q1 2022

May 16, 2022
BUY
$9.69 - $9.81 $7,752 - $7,848
800 Added 0.15%
532,185 $5.22 Million
Q4 2021

Feb 14, 2022
BUY
$9.68 - $9.77 $787,864 - $795,190
81,391 Added 18.09%
531,385 $5.17 Million
Q2 2021

Aug 25, 2021
BUY
$9.65 - $9.95 $4.34 Million - $4.48 Million
449,994 New
449,994 $4.35 Million

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email